Drug Properties and Optimization - 1

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/40

encourage image

There's no tags or description

Looks like no tags are added yet.

41 Terms

1
New cards

Drug–target binding

Interaction between a drug and biological target that can alter target activity and produce a response.

2
New cards

Noncovalent interactions

Attractions involved in drug binding, including electrostatic, hydrogen-bond, dipole and dispersion interactions.

3
New cards

Binding selectivity

Preference for one biological target based on the pattern and arrangement of molecular interactions.

4
New cards

Electrostatic interactions

Attraction between oppositely charged groups; relatively strong and non-directional.

5
New cards

Electrostatic environment

Charged interactions are often stronger inside hydrophobic pockets than when exposed to water.

6
New cards

Hydrogen bonding

Directional attraction requiring a hydrogen-bond donor and acceptor; strength depends on geometry and environment.

7
New cards

Hydrogen-bond donor

Group providing hydrogen from an appropriate bond, commonly O–H or N–H.

8
New cards

Hydrogen-bond acceptor

Atom providing an available lone pair, commonly oxygen or nitrogen in suitable functional groups.

9
New cards

Dipole–dipole interactions

Attraction between permanent partial charges in polar groups; depends on orientation, distance and environment.

10
New cards

van der Waals interactions

Weak attractions from temporary electron fluctuations; many close contacts collectively strengthen binding.

11
New cards

Desolvation

Displacement of water during binding; disrupting water interactions has an energetic cost.

12
New cards

Biological assay

Experiment measuring drug activity, either qualitatively or quantitatively.

13
New cards

In vitro vs. in vivo

In vitro tests occur outside a whole organism; in vivo tests occur within a living organism.

14
New cards

Assay levels

Biochemical tests use purified components; cell, tissue and in vivo tests use increasingly complex systems.

15
New cards

High-throughput screening

Automated testing of many compounds at one or a few concentrations to identify potential hits.

16
New cards

Quantitative follow-up

Testing multiple concentrations to measure concentration–response relationships and compare potency.

17
New cards

Potency

Amount or concentration needed for a specified effect; lower required concentration means greater potency.

18
New cards

Efficacy

Maximum effect a drug can produce, distinct from the concentration required to produce an effect.

19
New cards

Structure–activity relationship (SAR)

Relationship between molecular structural changes and changes in biological activity.

20
New cards

Structure–property relationship (SPR)

Relationship between structural changes and physicochemical or biological drug properties.

21
New cards

Drug-like molecule

Compound balancing activity, selectivity, suitable properties, target access and practical development.

22
New cards

Drug property measurements

Solubility, pKa, lipophilicity, molecular weight, permeability, melting point, metabolic stability and protein binding.

23
New cards

Biological barriers

Structures limiting drug movement toward targets; molecular properties influence how much drug crosses.

24
New cards

Hydrophilic groups

Groups interacting favourably with polar water through interactions such as hydrogen bonding and dipoles.

25
New cards

Lipophilic groups

Groups interacting favourably with nonpolar lipid environments, largely through dispersion interactions.

26
New cards

Membrane phospholipids

Molecules such as phosphatidylcholine with polar heads and nonpolar fatty acid tails.

27
New cards

Passive membrane permeability

Drug movement through lipid bilayers without direct energy input; requires entering the nonpolar interior.

28
New cards

Solubility–permeability balance

Need for sufficient aqueous dissolution and sufficient ability to cross lipid membranes.

29
New cards

Drug ionization

Existence of charged and neutral forms; charged forms generally favour water, neutral forms passive diffusion.

30
New cards

Acid–base equilibrium

Reversible gain or loss of H⁺ between protonated and deprotonated forms, influenced by pH and pKa.

31
New cards

pH and pKa

pH describes solution acidity; pKa characterizes an ionizable group and helps predict protonation.

32
New cards

Ka and pKa

Ka measures acid dissociation; pKa = −log₁₀(Ka). Lower pKa indicates a stronger acid.

33
New cards

Acid ionization

Below pKa, an ordinary carboxylic acid is mainly neutral; above pKa, mainly negative.

34
New cards

Base ionization

Below the conjugate acid's pKa, an ordinary amine is mainly positive; above pKa, mainly neutral.

35
New cards

pH equal to pKa

Condition where protonated and deprotonated forms are present in equal proportions.

36
New cards

Amphiprotic groups

Groups able to act as acids or bases; both pKa values may exist, but not both are necessarily relevant.

37
New cards

Relevant aqueous pKa range

Water's reference pKa values are about −1.7 for H₃O⁺ and 15.7 for H₂O; extreme values may be irrelevant.

38
New cards

Estimating pKa

Identify ionizable groups, classify acid/base behaviour, compare structural analogues and consider nearby effects.

39
New cards

Structural effects on pKa

Resonance, conjugation, inductive effects and nearby electron-withdrawing or donating groups alter acidity.

40
New cards

Nitrogen functional groups

Nitrogen ionization depends on functional group and conjugation; not all nitrogens behave like simple amines.

41
New cards

Ionization and solubility

For a carboxylic acid, higher pH favours charged carboxylate and water solubility over octanol solubility.